Development of EEHV-specific nanobodies as treatment for EEHV-hemorrhagic disease

Projects highlighted are not comprehensive of all IEF projects. Markers are an estimate of project location.

Development of EEHV-specific nanobodies as treatment for EEHV-hemorrhagic diseaseInternational Elephant Foundation2023-04-08T20:18:42-05:00

Development of EEHV-specific Nanobodies as Treatment for EEHV-hemorrhagic Disease

Asian Elephant (Elephas maximus) cute calf portrait

Elephant Endotheliotropic Herpesviruses (EEHV) are a group of elephant-specific viruses that may cause acute, highly lethal haemorrhagic disease in young elephants. Building upon previous work that developed a set of EEHV-specific nanobodies, this project seeks to identify EEHV-neutralizing nanobodies to be used as future prophylaxis or treatment.

IEF #EX1034

Project Years: 2023

Project Partners:
Utrecht University, The Netherlands

The International Elephant Foundation (IEF) is a non-profit 501(c)(3) corporation of individuals and institutions dedicated to the conservation of African and Asian Elephants worldwide.

IEF #EX1034

Contact IEF

Learn More!

Support IEF

Join our Conservation
E-news Family!

IEF #EX1034

Share This Story, Choose Your Platform!

Contact IEF

Learn More!

Support IEF

Join our Conservation E-news Family!

Join our Conservation
E-news Family!